MedPath

Effects of video presented information about Excimer laser therapy on comprehension and satisfaction with informed consent

Not Applicable
Completed
Conditions
Excimer laser treatment for ametropia
Eye Diseases
Registration Number
ISRCTN54821973
Lead Sponsor
Augenklinik Luzerner Kantonsspital [Cantonal Hospital Lucerne Eye Clinic]
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
86
Inclusion Criteria

1. Patients assessing refractive excimer laser therapy for ametropia at the refractive centre of the LUKS will be evaluated at their initial visit for study inclusion
2. Signed written informed consent form

Exclusion Criteria

1. Inability to follow the procedures of the study due to i.e. language problems, psychological disorders, dementia etc
2. Aged < 18 years
3. Enrolment of the investigator, his/her family members, employees and other dependent persons

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patients knowledge is measured using five multiple choice questions with five statements after the consultation.
Secondary Outcome Measures
NameTimeMethod
<br> 1. Patients’ satisfaction is measured using a questionnaire after the consultation.<br> 2. Anxiety levels is measured using a subpart of the State-Trait Anxiety Inventory 42 after the consultation.<br> 3. Perceived contact time measured using a questionnaire after the consultation.<br>
© Copyright 2025. All Rights Reserved by MedPath